Steven Mulcahy

Steven Mulcahy has a diverse work experience in the field of clinical operations and development. Steven is currently working as the Head of Clinical Operations at NervGen Pharma Corp. Prior to this, they held the position of Head of Clinical Operations at Oragenics, Inc. from 2019 to 2021. Steven has also worked as the Director of Clinical Operations and Development at Medday Pharmaceuticals from 2017 to 2018 and as an Independent Consultant from 2012 to 2017. Earlier in their career, Steven has held various roles including Director of Clinical Operations at AGENEBIO, Projects Director at INC Research, Director of Operations and Regulatory Affairs Clinical Research Services at Univ. of Pittsburgh Medical Center/Univ. of Pittsburgh Cancer Institute, and Sr. Manager of Medical and Scientific Affairs Oncology and Manager of Clinical Operations - CNS at Cephalon, Inc. Steven started their career as a Clinical Research Coordinator at the University of Pittsburgh. Through their roles, Steven has gained extensive experience in managing clinical trials, overseeing research operations, and building relationships with sponsors and customers.

Steven Mulcahy completed their Bachelor of Arts (B.A.) degree in Business and Communications from Carlow University in 1997. Steven then pursued a Master of Science (M.S.) degree in Professional Leadership, Health Care and Administration from the same university, which they obtained in 2000.